+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rx/Reimbursement Adult Incontinence in Kazakhstan

  • ID: 4517566
  • Report
  • March 2019
  • Region: Kazakhstan
  • 13 pages
  • Euromonitor International
1 of 2
In order to be reimbursed by the healthcare insurance scheme adult incontinence had to be prescribed by a doctor in 2018, which entailed a certain amount of bureaucracy. Even so, there were also limits on the amount of state support available. For instance, the law limits support to 730 units of Rx/reimbursement adult incontinence per person per year, or two units per day.

The Rx/Reimbursement adult incontinence in Kazakhstan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2023 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 2
Rx/reimbursement Adult Incontinence in Kazakhstan

List of Contents and Tables
Headlines
Prospects
Many Consumers Have Limited Access To Rx/reimbursement Adult Incontinence
Ageing Population Is Expected To Grow, Leading To Rising Demand for Rx/reimbursement Adult Incontinence
Rx/reimbursement Faces Competition From Retail Adult Incontinence
Category Data
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2013-2018
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2013-2018
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
Executive Summary
Economic Factors Support Growth
Affordability and Accessibility Are Two of the Main Criteria for Kazakhstani Consumers
Intense Competition Between Companies
Modern Grocery Retailers Support the Development of Tissue and Hygiene
Innovations in Materials and Technology To Drive Sales
Market Indicators
Table 5 Birth Rates 2013-2018
Table 6 Infant Population 2013-2018
Table 7 Female Population by Age 2013-2018
Table 8 Total Population by Age 2013-2018
Table 9 Households 2013-2018
Table 10 Forecast Infant Population 2018-2023
Table 11 Forecast Female Population by Age 2018-2023
Table 12 Forecast Total Population by Age 2018-2023
Table 13 Forecast Households 2018-2023
Market Data
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2013-2018
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2013-2018
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2014-2018
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2015-2018
Table 18 Distribution of Retail Tissue and Hygiene by Format: % Value 2013-2018
Table 19 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2018
Table 20 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll